Meticulous Research®—a leading global market research company, published a research report titled “North America LIMS Market by Mode of Delivery [On-premise, Cloud], Component [Service, Software], Type [Multi-purpose, Purpose-built], End User [Life Science, Food & Beverage, Petrochemical, Oil & Gas, Chemical, Environmental Industry) - Forecast to 2030.”
According to this latest publication from Meticulous Research, the North America LIMS market is expected to grow at a CAGR of 7.1% to reach $763.5 million by 2030. The growth of this market is driven by factors such as increasing R&D activities in the life sciences industry, the growing use of automation in laboratories, technological advancements in laboratory informatics solutions, and the rising need to comply with regulatory frameworks. However, cost constraints are restraining the market’s growth.
The increasing adoption of cloud-based LIMS is expected to offer significant market growth opportunities. However, the migration from legacy LIMS to new systems and data security & privacy concerns pose a major challenge to the market’s growth.
The key players profiled in the North America LIMS market report are LabWare, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), LabVantage Solutions Inc. (U.S.), LabLynx, Inc. (U.S.), Labworks LLC (U.S.), Agilent Technologies, Inc. (U.S.), Labii Inc. (U.S.), Accelerated Technology Laboratories, Inc. (U.S.), LABTrack (U.S.), Computing Solutions, Inc. (U.S.), Ovation (U.S.), CloudLIMS.com (U.S.), STARLIMS Corporation (U.S.), Illumina, Inc. (U.S), and Novatek International (Canada).
North America LIMS Market: Future Outlook
The North America LIMS Market is segmented based on Mode of Delivery [Web and Cloud-based LIMS, and On-premise LIMS], Offering [Software and Services], Type [Multi-purpose LIMS and Purpose-built LIMS], End User (Life Sciences [Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Biobanks & Biorepositories, Contract Research Organizations (CROs), and Other Life Sciences End Users]), Food & Beverage Industry, Petrochemicals and Oil & Gas Industries, Chemical Industry, Environmental Testing Laboratories, and Other End Users]). The study also evaluates industry competitors and analyzes the market at the country level.
Based on offering, the North America LIMS market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the North America LIMS market. The large market share of this segment is attributed to the rising demand for laboratory automation, advancements in LIMS software technologies, and the growing requirement to seamlessly integrate LIMS software with existing laboratory systems.
Based on mode of delivery, the North America LIMS market is segmented into web & cloud-based LIMS and on-premise LIMS. In 2023, the web & cloud-based LIMS is expected to account for the largest share of the North America LIMS market. The large market share of this segment can be attributed to cost-effectiveness, real-time analysis capabilities, easy access to data, internal and external data sharing, flexibility, and scalability offered by web & cloud-based LIMS.
Based on type, the North America LIMS market is segmented into multi-purpose LIMS and purpose-built LIMS. In 2023, the multi-purpose LIMS segment is expected to account for the largest share of the North America LIMS market. The large market share of this segment can be attributed to the benefits offered by multiple-purpose LIMS, such as reduced IT overheads, data standardization, and better collaborations across the organization. Furthermore, the flexibility and value-added modules these systems offer make them suitable for research and development labs, stability labs, environmental monitoring labs, quality testing labs, preclinical labs, and clinical trial testing labs.
Based on end user, the North America LIMS market is segmented into life sciences, food & beverage industry, petrochemicals and oil & gas industries, chemical industry, environmental testing laboratories, and other end users. In 2023, the life sciences segment is expected to account for the largest share of the North America LIMS market. The life sciences segment is further divided into pharmaceutical & biotechnology companies, academic & research institutes, biobanks & biorepositories, contract research organizations (CRO), and other life sciences end users. The large market share of this segment can be attributed to the increased regulatory pressures on pharmaceutical companies to maintain data integrity, validity, and security; rising R&D activities; and the growing need to improve laboratory productivity and cost efficiency.
This research report provides a comprehensive analysis of the U.S. and Canada. In 2023, the U.S. is expected to account for the largest share of the North America LIMS market. The ease of availability of LIMS services and products, stringent regulatory requirements, advanced infrastructure, and increased adoption of laboratory automation primarily drives the growth of this market.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5553
Key Questions Answered in the Report-
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029Read More